Version Française
The VideoFor PatientsThe TreatmentThe Company


There are relatively few reasons why an individual might not qualify for a Sonocur® treatment but the following will disqualify a potential patient from treatment:

Listed below are contraindications for treatment including information on contraindicated prescriptions and a review of the importance of localized, palpable pain. Please take a moment to review this important information.

    1. Poorly localized or non palpable area of pain.

    2. No recent X-ray, CT scan or MRI of the area

    3. Pregnancy

    4. A bleeding disorder such as hemophilia or an acquired bleeding disorder

    5. Blood dyscrasia or other disorder with platelet count less than 50,000

    6. An open wound over the site to be treated

    7. Redness, swelling, fever, or other evidence of infection or acute inflammation at the site to be treated

    8. Uncooperative patient or one who cannot follow directions (Alzheimer's disease, senile dementia, organic brain syndrome, etc.)

Prescriptions and Allergies

  • Patients should take their regular medications during their series of treatments.

  • Patients on Coumadin (Wafarin) or other anti-coagulants should not be treated.

  • Patients may continue taking aspirin or other non-steroidal anti-inflammatory agents during their series of treatment.

  • Latex hypersensitivity is not a contraindication to therapy.


In addition to imaging studies, all patients selected for Sonocur® therapy should have palpable, localized, areas of pain.  If these criteria are not met, the treatment should not be done. Although the best results of treatment are in patients with a single, palpable painful site, up to three areas of localized pain at a single site may be treated at one treatment session (e.g. shoulder).

It cannot be overstated how important this selection criteria is. Patients with diffuse, non-localized pain should not be treated.  If a patient is referred with a non-localized pain, he or she should be returned to the referring physician with the appropriate "Extracorporeal Shockwave Therapy Exclusion Form".

The Sonocur® Orthopedic Extracorporeal Shockwave system is available in Canada and other countries where regulatory approval has been obtained. The Sonocur® Basic is FDA approved in the United States for the treatment of chronic lateral epicondylitis (tennis elbow).

© 2012 Sonorex. All rights reserved. By using this service, you accept the terms of our Visitor Agreement. Please read it. The material is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen.